Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal Cancer

Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal Cancer

Colorectal cancer (CRC) is one of the leading causes of world cancer deaths. To improve the survival rate of CRC, diagnosis and post-operative monitoring is necessary. Currently, biomarkers are used for CRC diagnosis and prognosis. However, these biomarkers have limitations of specificity and sensit...

Full description

Bibliographic Details
Main Authors: Ji Hun Suh, Min Chul Park, Peter C. Goughnour, Byung Soh Min, Sang Bum Kim, Woo Yong Lee, Yong Beom Cho, Jae Hee Cheon, Kang Young Lee, Do-Hyun Nam, Sunghoon Kim
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
lysyl-trna synthetase
colorectal cancer
serologic biomarker
diagnosis
monitoring
noninvasive method
Online Access:https://www.mdpi.com/2077-0383/9/2/533

Internet

https://www.mdpi.com/2077-0383/9/2/533

Similar Items